Service Providers
- Name of Company
- NEUROPHET Inc.
- Address
- 12F, 124, Teheran-ro-, Gangnam-gu, Seoul, Republic of Korea
- Key Services
-
- Clinical CRO
- Consulting
- Decentralized Clinical Trial(DCT)
- Homepage(English)
- https://www.neurophet.com/en
- Sales(end of 2024)
- NR
- Human Resources Status
- NR
- Number of audit of Regulatory agency(ex FDA/EMA, etc.)
- NR
- ISO 9001
- Not Provided
- Status of Additional Certifications
- ISO 13485 (Medical Devices Quality Management System), ISO 27001 (Information Security Management), ISO 27701 (Privacy Information Management)
- Key Strengths
-
Neurophet’s Imaging CRO strength lies in combining central imaging core lab operations, AI-powered neuroimaging analysis, regulatory-grade imaging workflows, and clinical trial execution support. Rather than functioning only as an imaging software provider, Neurophet can position itself as an end-to-end neuroimaging partner supporting sponsors from study design to imaging endpoint assessment. A key differentiator is Neurophet’s focus on neurology and neurodegenerative disease trials, particularly Alzheimer’s disease and related disorders. The company’s platform covers both MRI and PET modalities, supporting quantitative analysis of brain atrophy, white matter hyperintensity, amyloid/tau/FDG PET biomarkers, ARIA-related imaging findings, lesion tracking, and longitudinal disease progression. This allows sponsors to generate imaging-based evidence for patient selection, safety monitoring, efficacy evaluation, and regulatory decision-making.
- Introduction Materials (Upload attachment)
-
-
- Clinical Operation
- Provided
- Medical Writing
- Not Provided
- Statistics
- Not Provided
- Data Management
- Provided
- Regulatory Affairs
- Provided
- Pharmacovigilance
- Not Provided
- Vendor Management
- Provided
- Consulting
- Not Provided
- Feasibility Service
- Not Provided
- Medical Monitoring
- Not Provided
- Training and Education
- Provided
- IT Solution
- Not Provided
- CDISC data service
- Not Provided
- Project Management
- Provided
- Online Subject Recruitment
- Not Provided
- E-Consent
- Not Provided
- IP (Investigational Product) Delivery
- Not Provided
- Remote Study (Remote Monitoring & Telemedicine)
- Not Provided
- In-home Research (Home Visits to the Subject’s Residence for Specimen Collection Including Blood Collection and Vital Sign Assessment)
- Not Provided
- Off-site Data Collection – Self-Collection of Specimens (e.g., Personal Diagnostic Kits)
- Not Provided
- Off-site Data Collection – Self-Measured Health Data (e.g., Personal Health Management Products, Wearable Devices, Medication Adherence Tools)
- Not Provided
- Cardiovascular Disease (CVD)
- Not Provided
- Diabetes / Endocrine Disorders
- Not Provided
- Respiratory Diseases
- Not Provided
- Sleep Disorders / Sleep Apnea
- Not Provided
- Obesity / Metabolic Syndrome
- Not Provided
- Medication Management (Electronic Pill Bottle, Recording Medication Intake, etc.)
- Not Provided
- Off-site data collection – self-report(ePRO/eCOA)
- Not Provided
- Remote Data Monitoring
- Provided
- Other
- Consulting
- Provided